Site Search

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry that is working to improve the drug development process and so accelerate the development of better, safer medicines for patients. IMI works by forging ...

Brussels, Belgium, 10 August 2015 – The excellence of research supported by the Innovative Medicines Initiative (IMI) is confirmed by a detailed analysis of scientific papers produced by IMI projects. The analysis, carried out by Thomson Reuters and published online today ...

​​​​​​​Brussels, Belgium, 9 July 2015 – Today, the Innovative Medicines Initiative (IMI) is launching its 5th Call for proposals under the IMI 2 programme. IMI 2 – Call 5 has a total budget of €95 million and features 6 topics. Of these, four focus on different aspects of ...